Method For Optogenetic Treatment Of Blindness Including Retinitis Pigmentosa

Tech ID: 31702 / UC Case 2009-374-0

Brief Description

Retinitis pigmentosa (RP) refers to disorders characterized by degeneration of photoreceptors in the eye which hinders visual ability by nonfunctional neuronal activation and transmission of signals to the cortex. The prevalence of this disease is at least one million individuals.

The optogenetic treatment is based on a very recent phenomenon where chemically identical neurons can be activated by blue light with high temporal precision by introducing a light-activated molecular channel, named channelrhodopsin-2 (ChR2), into specific groups of cells by genetic targeting. There is a need of a systematic method for nonviral delivery of the ChR2 gene into retinal ganglion cells of the adult retina so as to create visually evoked potentials in the visual cortex.

The illustrated embodiments of the invention includes an in vivo method for sensitizing retinal ganglion cells in an eye without use of viral transfection includes the steps of nonviral in vivo delivering of gene coding for channelrhodospsin-2 (ChR2) or any photosensitive genetic material now known or later devised to target the retinal ganglion cells of a retina by intravitreous injection of plasmid DNA; and electroporating the plasmid into the retina. In addition to intravitreous injection of plasmid DNA or photosensitive genetic material, plasmid DNA or photosensitive genetic material may be inserted into the eye by ionotophoresis of the plasmids into the eye.

Full Description

Suggested uses

Advantages

Patent Status

Country Type Number Dated Case
United States Of America Issued Patent 9,089,698 07/28/2015 2009-374
 

Contact

Learn About UC TechAlerts - Save Searches and receive new technology matches

Other Information

Categorized As

  • AN INTEGRAL PART OF
  • Institute for Innovation Logo
  • Institute for Innovation Logo

University of California, Irvine Invention Transfer Group
5141 California Avenue, Suite 200, Irvine,CA 92697-7700
Tel: 949.824.2683 | Fax: 949.824.3880
www.ota.uci.edu | ota@uci.edu

© 2019, The Regents of the University of California
Terms of use | Privacy Notice